x

In Vitro Fertilization and the SSI

Our Clinic has an agreement with the Social Security Institution (SSI). Patients with the appropriate report for IVF treatment can be treated in our clinic using these reports. For the report of the treatment of IVF, patients are required to provide the following conditions as published by the Social Security Institution.

Social Security Institution Health Practice Communication (SUT 2012)

4.5.4.K- Treatments of assisted reproduction method

(1) in vitro fertilization procedures (IVF) is considered as an "assisted reproductive method" as defined in Article 63 of the Law No. 5510. Ovulation induction (OI) and intrauterine insemination (IUI) procedure are not considered in this context.

4.5.4.K.1- In vitro Fertilization (IVF)

(1) Provided that although married, one of the spouses does not have any child alive except for those adopted, expenses for IVF treatment to be limited to a maximum of two attempts (cycles) for couples with health insurance shall be borne by the Institution if the conditions set out below occur together;

a) If there is a medical board report issued certifying that he/she could not have a child with medical methods after the treatments performed, but may have children only with assisted reproductive method,

b) If he/she turns 23 years of age and not under the age of 40,

c) If the center providing treatment is under contract with the Institution,

d) If he/she has been general health insured at least since five years or is the person he/she is obliged to take care of, has 900 days of general health insurance or if husband carries the necessary conditions in case the woman with general health insurance does not provide the conditions set forth herein,

e) If health boards of the health service providers under contract with the Institution certifies that no result could be obtained with other treatment methods in the last three years.

(2) In the event that the woman receiving IVF treatment turns (the date of embryo transfer) 40 years of age, expenses for the treatment shall not be borne by the Institution even the treatment has been initiated at an earlier date. For example, for covering treatment expenses of a woman born March 8, 1985, IVF treatment must be performed after the date of March 8, 2008 and before the date of March 8, 2024.

(3) Expenses previously paid for IVF treatments by the social security institutions, transferred to the Institution, shall be taken into account in calculation of the number of attempts.

(4) For payment of the expenses of IVF treatment, the medical board report shall state that the woman who will receive IVF treatment does not have any systemic disorder which may may interfere with the maintenance of pregnancy.

4.5.4.K.1.1- Indications for IVF

a) Male factor: Aligoasthenospermia and azoospermia cases where total motile sperm count is less than 5 million in each of three separate semen analyses performed at intervals of at least 15 days with in spite of uro-andrological treatment,.

b) Female factor:

1-Tubal factor: Cases with primary ciliary dyskinesia - Kartegener Syndrome, bilateral full tubal obstruction (severe distal tubal disease, organic bilateral proximal tubal obstruction, bilateral tubal obstruction or lack of tubes), cases with severe pelvic adhesions or that cannot become pregnant after tubal surgery (laparoscopy or open surgery).

2-Endometriosis: Mild and moderate endometriosis, advanced stage (stage 3-4) endometriosis.

3-Hormonal - ovulatory disorders: Cases unresponsive to the standard treatment in anovulation in WHO Group I-II patients.

c) Unexplained infertility: Failure of conception for 3 years or a longer period from the date of marriage despite examinations of both the man and woman are normal and implementation of at least two attempts of OI + IUI with gonadotropins.

d) Other indications: Cases with poor ovarian responses or low ovarian reserves.

4.5.4.K.1.2- Health Board Report

(1) The medical board report required for IVF treatment will be issued by health boards established with participation of two gynecologists and obstetricians and one urologist in tertiary health institutions with a department of obstetrics and gynecology and a urology clinic within (including obstetrics hospitals that do not contain a urology clinic but where a urology experts serves as consultant physician and hospitals providing training).

(2) Health board reports should state patient's age, identification, diagnosis, indication, treatment to be administered and in addition, daily and maximum doses of the drugs to be used shall be included in health board reports taking into account the provisions of Article 6.2.42.B.

(3) Health Board Reports should state that;

a) For male factor; pregnancy could not be achieved despite "OI + IUI" treatment administered by giving gonadotropin of two cycles in cases with a total progressive motile sperm count higher than 5 million in oligoasthenozoospermia (this condition is not required for oligoasthenozoospermia cases oligoasthenozoospermia and azoospermia cases of less than 5 million),

b) pregnancy could not be achieved for a year after endometriosis treatment or after "OI + IUI" treatment administered by giving gonadotropin of two cycles following surgical treatment in cases with advanced stage (stage 3-4) endometriosis,

c) pregnancy could not be achieved after "OI + IUI" treatment administered by giving gonadotropin of two cycles in cases with mild and moderate endometriosis,

d) pregnancy could not be achieved after "OI + IUI" treatment administered by giving gonadotropin of two cycles in cases of unexplained infertility.

However;

a) In the presence of primary ciliary dyskinesia-Kartegener Syndrome,

b) in cases detected a full bilateral tubal obstruction approved by laparoscopy (severe distal tubal disease, organic bilateral proximal tubal obstruction, bilateral tubal obstruction or lack of tubes),

c) in cases with severe pelvic adhesions or could not becaome pregnant within a year after tubal surgery (laparoscopy or open surgery),

d) in cases unresponsive to the standard treatment in anovulation in WHO Group I-II patients, pre-IVF.OI and / or OI + IUI" will not be required provided that clinical and laboratory findings that form the basis of the diagnosis shall be included in the medical board report.

(4) Health Boards will be required to issue a new report if the treatment of IVF is not performed within 6 (six) months from the date of the board's report. However, if any drugs are provided with this period, the drugs provided shall be taken into account in maximum dose calculation.

(5) The second IVF treatment also requires a new health board report.

  • get an appointment
  • ask a question

Dr. Hakan Özörnek'in kaleme aldığı "Bebek İstiyorum" kitabını ücretsiz olarak indirmek için kayıt olabilirsiniz.

X